Involvement of the Warburg effect in non‐tumor diseases processes
Z Chen, M Liu, L Li, L Chen - Journal of cellular physiology, 2018 - Wiley Online Library
Warburg effect, as an energy shift from mitochondrial oxidative phosphorylation to aerobic
glycolysis, is extensively found in various cancers. Interestingly, increasing researchers …
glycolysis, is extensively found in various cancers. Interestingly, increasing researchers …
Pulmonary hypertension and right ventricular failure in emergency medicine
Pulmonary hypertension is a hemodynamic condition, defined as a mean pulmonary artery
pressure by right-sided heart catheterization of at least 25 mm Hg at rest. It is classified into 5 …
pressure by right-sided heart catheterization of at least 25 mm Hg at rest. It is classified into 5 …
Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study
RC Deaño, C Glassner-Kolmin… - JAMA internal …, 2013 - jamanetwork.com
Importance Pulmonary hypertension (PH) is a fatal disease. Although the prognosis of
pulmonary arterial hypertension (PAH) has improved with targeted therapies, the outcome is …
pulmonary arterial hypertension (PAH) has improved with targeted therapies, the outcome is …
Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming
JP Fessel, R Hamid, BM Wittmann… - Pulmonary …, 2012 - journals.sagepub.com
Pulmonary arterial hypertension (PAH) is a progressive and fatal disease of the lung
vasculature for which the molecular etiologies are unclear. Specific metabolic alterations …
vasculature for which the molecular etiologies are unclear. Specific metabolic alterations …
A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2)
HM Lazarus, J Denning, S Wring… - Pulmonary …, 2022 - Wiley Online Library
Serotonin plays a key role in the development and maintenance of the pathobiology
associated with pulmonary arterial hypertension (PAH). Platelet‐driven and locally produced …
associated with pulmonary arterial hypertension (PAH). Platelet‐driven and locally produced …
[HTML][HTML] App-based versus standard six-minute walk test in pulmonary hypertension: mixed methods study
D Salvi, E Poffley, L Tarassenko… - JMIR mHealth and …, 2021 - mhealth.jmir.org
Background Pulmonary arterial hypertension (PAH) is a chronic disease of the pulmonary
vasculature that can lead to heart failure and premature death. Assessment of patients with …
vasculature that can lead to heart failure and premature death. Assessment of patients with …
Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis
A Shahane - Rheumatology international, 2013 - Springer
The focus of this review is to increase awareness of pulmonary arterial hypertension (PAH)
in patients with rheumatic diseases. Epidemiology and pathogenesis of PAH in rheumatic …
in patients with rheumatic diseases. Epidemiology and pathogenesis of PAH in rheumatic …
Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies
AB Waxman, RT Zamanian - The American journal of cardiology, 2013 - Elsevier
Pulmonary arterial hypertension (PAH), which is a subset of pulmonary hypertension, is a
group of diseases distinguished by vascular remodeling of the small pulmonary arteries with …
group of diseases distinguished by vascular remodeling of the small pulmonary arteries with …
Right heart failure: A narrative review for emergency clinicians
Introduction Right heart failure (RHF) is a clinical syndrome with impaired right ventricular
cardiac output due to a variety of etiologies including ischemia, elevated pulmonary arterial …
cardiac output due to a variety of etiologies including ischemia, elevated pulmonary arterial …
Riociguat: first global approval
D Conole, LJ Scott - Drugs, 2013 - Springer
Riociguat (Adempas®), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is
under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of …
under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of …